Suggestions
Julien de Salaberry
Founder | CEO | Influencer | Venture Partner | Board Advisor | Speaker | Author | Photographer
Julien de Salaberry is a prominent figure in the healthcare and digital health industry, serving as the CEO and Founder of Galen Growth, a global leader in Digital Health private market data, intelligence, and analytics.12
Professional Background
With over 25 years of experience in healthcare, de Salaberry has worked with leading brands such as Eli Lilly, Boston Scientific, Baxter, GSK, and Merck & Co.1 His extensive international business experience spans Europe, the Middle East, and Asia, giving him a deep understanding of organic and inorganic growth in healthcare across both developed and emerging markets.1
Career Highlights
Galen Growth:: Founded in November 2015, this company provides insights to Fortune 500 corporations and institutional investors in the healthcare sector.14
The Propell Group:: In 2012, de Salaberry founded this boutique venture investor firm focusing on promising HealthTech startups.1
Global Cancer Research & Commercialisation Fund:: Co-founded in 2016 to foster collaboration between research institutes, foundations, and investors worldwide.1
Education and Early Career
De Salaberry holds an MBA from Cranfield School of Management and a BEng from the University of Portsmouth.1 Interestingly, he began his career as a Naval Officer in the Royal Navy, serving from 1990 to 1996.1
Thought Leadership
As a healthcare change catalyst and evangelist, de Salaberry challenges the status quo in healthcare while understanding the industry's complexities.1 He is a regular speaker on HealthTech and Digital Health Innovation and has authored two books:
Both books focus on technology innovation and its impact on humans, the ecosystem, and the economy.2
Philosophy and Vision
De Salaberry strongly believes that medicine and healthcare are being transformed by Deep Tech, presenting unprecedented opportunities for better patient outcomes.1 He advocates for leveraging data and technology to make more informed decisions in the healthcare industry.3
